Person: Dr Pierre Chartrand

Dr Pierre Chartrand

Dr Pierre Chartrand has been appointed interim director of the Canadian Institutes of Health Research effective last month, replacing the outgoing Dr Alan Bernstein. Chartrand is CIHR’s VP research and will remain in the top spot until a permanent replacement is found. Dr Nancy Edwards, CIHR’s governing council vice-chair, will assume the chairperson function until…

Dr Lisa McKerracher

Dr Lisa McKerracher has been appointed CEO of privately held Emerillon Therapeutics Inc. McKerracher joined the Montreal-based company last August to refocus its multiple technologies toward product development and clinical trials. She has been a professor at both McGill Univ and the Univ of Montreal and left academic research to become the founding scientist and…

Maxim Jean-Louis

Maxim Jean-Louis has been appointed board chair of the Optical Regional Advanced Network of Ontario, the owner-operator of ORION. He replaces Dr Stan Shapson. Jean-Louis is the president and CEO of Contact North/Contact Nord, a position he has held since 1996. The organization is a network of distance education and training access centres reaching 90…

Dr Bernie Bressler

Dr Bernie Bressler has been appointed chair of the board of trustees for Discovery Parks Trust, an operator of office and laboratory research space for the technology and life sciences sectors. He replaces Gerald McGavin, a Vancouver businessman and philanthropist who has held the position since 1987. Bressler is VP research at Vancouver Coastal Health,…

Dr Chad Gaffield

Dr Chad Gaffield has been selected as the new president of the Social Sciences and Humanities Research Council (SSHRC). Gaffield is a full professor in the faculty of arts and former director of the Institute of Canadian Studies at the Univ of Ottawa, an organization he founded in 1997. He currently holds a Canada Research…

Dr Pierre Chartrand

Dr Pierre Chartrand has been appointed VP research at the Canadian Institutes of Health Research (CIHR), effective September 5. Chartrand comes to CIHR from the Univ of Montreal where he was CEO of the Institute for Research in Immunology and Cancer and a professor in the department of pathology and cellular biology. One of his…